{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:51:29Z","timestamp":1790639489023,"version":"4.1.0"},"reference-count":6,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S036407\/1"],"award-info":[{"award-number":["MR\/S036407\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["no Grant \/ Award Number"],"award-info":[{"award-number":["no Grant \/ Award Number"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHS Commissioning service for NMOSD","award":["no Grant \/ Award Number"],"award-info":[{"award-number":["no Grant \/ Award Number"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/jnnp-2021-326779","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T17:42:41Z","timestamp":1626284561000},"page":"334-335","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Frequency of MOG-IgG in cerebrospinal fluid versus serum"],"prefix":"10.1136","volume":"93","author":[{"given":"Samuel","family":"Pace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-9748","authenticated-orcid":false,"given":"Sarosh R","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4142-2667","authenticated-orcid":false,"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-6346","authenticated-orcid":false,"given":"Adam E","family":"Handel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"2022021507552022000_93.3.334.1","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"2022021507552022000_93.3.334.2","doi-asserted-by":"crossref","first-page":"10.1212\/WNL.0000000000008479","DOI":"10.1212\/WNL.0000000000008479","article-title":"Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases","volume":"93","author":"Mariotto","year":"2019","journal-title":"Neurology"},{"key":"2022021507552022000_93.3.334.3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.msard.2018.12.035","article-title":"Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: a case report","volume":"28","author":"Aoe","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"2022021507552022000_93.3.334.4","doi-asserted-by":"crossref","first-page":"10.1212\/WNL.0000000000007096","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"},{"key":"2022021507552022000_93.3.334.5","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0717-1"},{"key":"2022021507552022000_93.3.334.6","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012175","article-title":"Difference in the source of Anti-AQP4-IgG and Anti-MOG-IgG antibodies in CSF in patients with neuromyelitis optica spectrum disorder","author":"Akaishi","year":"2021","journal-title":"Neurology"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2021-326779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:12:38Z","timestamp":1644945158000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2021-326779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2,15]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/jnnp-2021-326779"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2021-326779","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}